Why Is Vanguard S&P 500 ETF (VOO) Down Today, 4/13/2026?
TipRanks (Mon, 13-Apr 9:09 AM ET)
Why Is the SPY ETF Down Today, 4/10/2026?
TipRanks (Fri, 10-Apr 6:56 PM ET)
Why Is Vanguard S&P 500 ETF (VOO) Up Today, 4/10/2026?
TipRanks (Fri, 10-Apr 8:41 AM ET)
HHS Secretary RFK Jr. overhauls CDC vaccine advisory committee rules
Seeking Alpha News (Fri, 10-Apr 6:50 AM ET)
Study Showing 50% Drop In COVID ER Visits Thanks To The Vaccine Put On Hold By CDC: Report
Benzinga (Fri, 10-Apr 5:58 AM ET)
Why Is the SPY ETF Up Today, 4/9/2026?
TipRanks (Thu, 9-Apr 6:02 PM ET)
Report on COVID vaccine benefits being delayed at CDC: WaPo
Seeking Alpha News (Thu, 9-Apr 10:56 AM ET)
Why Is Vanguard S&P 500 ETF (VOO) Down Today, 4/9/2026?
TipRanks (Thu, 9-Apr 8:59 AM ET)
Why Is the SPY ETF Up Today, 4/8/2026?
TipRanks (Wed, 8-Apr 5:48 PM ET)
RFK Jr. changes rules to select CDC vaccine advisors after legal setback
Seeking Alpha News (Wed, 8-Apr 10:13 AM ET)
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Moderna trades on the NASDAQ stock market under the symbol MRNA.
As of April 13, 2026, MRNA stock price climbed to $51.41 with 1,735,157 million shares trading.
MRNA has a beta of 1.36, meaning it tends to be more sensitive to market movements. MRNA has a correlation of 0.11 to the broad based SPY ETF.
MRNA has a market cap of $20.39 billion. This is considered a Large Cap stock.
Last quarter Moderna reported $678 million in Revenue and -$2.11 earnings per share. This beat revenue expectation by $39 million and exceeded earnings estimates by $.49.
In the last 3 years, MRNA traded as high as $170.47 and as low as $22.28.
The top ETF exchange traded funds that MRNA belongs to (by Net Assets): VTI, VOO, VB, VBR, IVV.
MRNA has outperformed the market in the last year with a return of +109.8%, while the SPY ETF gained +31.0%. In the last 3 month period, MRNA beat the market returning +49.9%, while SPY returned -1.8%. However, in the most recent 2 weeks MRNA has underperformed the stock market by returning +3.7%, while SPY returned +7.2%.
MRNA support price is $49.10 and resistance is $52.83 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MRNA shares will trade within this expected range on the day.
